Rituximab is a chimeric monoclonal antibody against CD20+ lymphocytes used to treat non-Hodgkin lymphoma, hematological and autoimmune diseases rheumatoid arthritis, systemic lupus erythematosus, thrombocytopenic purpura, hemolytic anemia, multiple sclerosis.The safety of the drug is critical to the choice of treatment.Rituximab-associated intersti
Background: Cleft lip and cleft palate are the most common congenital developmental deformities found worldwide.Children with oral clefts have a range of functional and esthetic complications.Hence, the successful management of children born with oral clefts requires coordinated rumchata proof care provided by several specialties.Knowledge of oral
Introduction Testing for inherited and acquired thrombophilias adds to the cost of care of patients with venous thromboembolism (VTE), though results may not influence patient management.Methods This is a single-center, retrospective study conducted at Emory University Hospitals from January to December 2015 to (1) determine the pattern of thrombop
Effective treatment approaches for patients with COVID-19 remain limited and are neither curative nor widely applicable.Activated hydrangea red sensation specialized tissue effector extracellular vesicles (ASTEX) derived from genetically-enhanced skin fibroblasts, exert disease-modifying bioactivity in vivo in models of heart and lung injury.Here w
Tobacco rattle virus (TRV) has a bipartite, positive-sense single-stranded RNA genome and is widely used for virus-induced gene silencing (VIGS) in plants.RNA1 of TRV that lacks the gene la rams crop top for the cysteine-rich 16K silencing-suppression protein infects plants systemically in the absence of RNA2.Here, we attempted to engineer RNA1 for